Labs / CDMO: development & manufacturing
Polypeptide
San Diego, CA, United States · polypeptide.com
GMP
PolyPeptide is a CDMO focused on peptide-based therapies and peptide active pharmaceutical ingredients for pharmaceutical and biotech customers worldwide. It develops and manufactures proprietary and generic peptide APIs for applications including metabolic disease, cancer, cardiovascular, and neurological disorders. The company operates in Europe, the US, and India.
They take quote requests through a form on their website with project details. Their quote form
What they offer
GMP peptide manufacturing
Manufactures GMP-grade peptides from initial gram quantities to commercial multi-kilogram or larger batches.
Pre-GMP development
Develops robust production approaches, analytical characterization, and methods for lead peptides before GMP manufacture.
Production process development
Develops small-scale to large-scale production processes for proprietary and generic peptides across development stages.
Quality assurance
Reviews batch records and releases product in compliance with cGMPs through site and global QA units.
Quality control
Provides analytical development, testing, and specifications to support API release and product life-cycle control.
GMP compliance and regulatory support
Supports manufacturing in compliance with ICH Q7 and provides documentation for product approval from IND to NDA.
Commercial manufacturing
Manufactures peptide products for commercial requirements and supports commercial production scale-up.
Custom R&D
Supports custom peptide projects, including custom research-grade peptides.
Radiolabeled peptide manufacturing
Produces radiolabeled peptides.
Generic peptide manufacturing
Provides services for generic peptides.
What they work on
- Modalities
- Small molecule, Peptide
- Species and models
- pre-GMP animal toxicology lots, Phase I clinical trial material, Phase II clinical trial material, Phase III material
- Assays and studies
- analytical development, MS/MS sequencing, UHPLC, amino acid composition, chiral purity, bioburden testing, endotoxin testing, assay (peptide content), identity testing, moisture content, residual solvents testing
- Instruments and platforms
- UHPLC, MS/MS
- Scale and capacity
- initial gram quantities, multi-kilograms or more per batch, mg quantities, metric tons, 6 sites on 3 continents
- Therapeutic areas
- metabolic diseases, diabetes, obesity, cancer, cardiovascular disorders, neurological disorders
- Turnaround
- quick turnaround times
- What to send
- lead peptide designated for GMP manufacture · pilot lots · pre-GMP animal toxicology lots
- Type
- CDMO
- Sites
- Baar, Switzerland · Limhamn, Sweden · Strasbourg, France · Braine-l’Alleud, Belgium · Torrance, USA · San Diego, USA
- Team
- 1,469 employees
- Quality
- ICH guidelines including Q7 · cGMP · other regulatory authorities inspections (facilities have been inspected by several other regulatory authorities)
- Serves
- North America, Europe, Asia, around the globe
- Address
- 365 Maple Avenue Torrance CA 90503 USA
- Founded
- 1952
Public records
Similar labs. DSK InnoSciences, RS Synthesis, ARSI Canada Inc, Aurigene Pharmaceutical Services
Found in the Biocom California CRO directory, a contract services directory. Listing built from polypeptide.com. Work here? Claim this listing.